Pediatric Infection and Vaccine

  • 제26권1호
  • /
  • Pages.71-79
  • /
  • 2019
  • /
  • 2384-1079(pISSN)
  • /
  • 2384-1087(eISSN)
대한소아감염학회 (The Korean Society of Pediatric Infectious Diseases)
권호 표지
DOI QR코드

DOI QR Code

A Child of Severe Mycoplasma pneumoniae pneumonia with Multiple Organ Failure Treated with ECMO and CRRT

  • Hwang, Woojin (Department of Pediatrics, Chungnam National University School of Medicine) ;
  • Lee, Yoonjin (Department of Pediatrics, Chungnam National University School of Medicine) ;
  • Lee, Eunjee (Department of Pediatrics, Chungnam National University School of Medicine) ;
  • Lee, Jiwon M. (Department of Pediatrics, Chungnam National University School of Medicine) ;
  • Kil, Hong Ryang (Department of Pediatrics, Chungnam National University School of Medicine) ;
  • Yu, Jae Hyeon (Department of Thoracic and Cardiovascular Surgery, Chungnam National University School of Medicine) ;
  • Chung, Eun Hee (Department of Pediatrics, Chungnam National University School of Medicine)
  • 투고 : 2018.09.18
  • 심사 : 2018.11.30
  • 발행 : 2019.04.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

8세 남아가 호흡곤란과 기면증을 보이며 응급실에 내원하였다. 극도의 호흡부전을 보이고 있었고 고유량의 산소 공급을 함에도 불구하고 88-90%로 밖에 유지되지 않았고 단순 흉부 방사선 검사에서 전 폐야에 불투과도가 증가하였고 중등도의 흉수를 보였다. 마이코플라스마 폐렴 진단 하에 정맥 macrolide 를 포함한 항생제 치료를 시작하였으나 2병일 째 간, 신장에 다기관 부전 및 급성 호흡부전 증상을 보였다. 정맥-정맥 체외순환막성산소화기를 삽입하였고 지속적 신대체요법도 병행하였다. 18병일 째 성공적으로 체외순환막성산소화기에서 이탈하였고 저산소성 뇌 손상 없이 성공적으로 치료되었기에 본 사례를 보고한다.

Mycoplasma pneumoniae (MP) is the most common causative agent of community-acquired pneumonia in school-aged children. An 8-year-old boy who had been diagnosed with autism looked severely ill when he presented to our hospital due to dyspnea and lethargy. He had fever and cough 7 days prior to hospitalization. He had signs and symptoms of severe respiratory distress. The percutaneous oxygen saturation was 88% at high oxygen supply. Chest radiography showed diffusely increased opacity with moderate pleural effusion. He was intubated immediately and admitted to the intensive care unit. Under the clinical impression of mycoplasmal pneumonia, intravenous clarithromycin was started. Laboratory findings showed leukocytosis, hepatitis, decreased renal function, and presence of serum MP immunoglobulin (Ig) M (+) IgG (+) and sputum MP polymerase chain reaction (+). On hospital day 2, the patient developed multiple organ failure with acute respiratory distress syndrome (ARDS). Veno-venous extracorporeal membrane oxygenation (ECMO) was performed with continuous renal replacement therapy (CRRT) and was weaned successfully. This is the first reported case of an ARDS due to MP infection complicated by multiple organ failure that was successfully treated with ECMO and CRRT in South Korea.

키워드

참고문헌

  1. Garo B, Garre M, Quiot JJ, Boles JM, Becq-Giraudon B, Chennebault JM, et al. Mycoplasma pneumoniae infections. A multicenter retrospective study of 182 cases. Presse Med 1988;17:1475-8.
  2. Marrie TJ. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med 1993;153:488-94. https://doi.org/10.1001/archinte.1993.00410040054008
  3. Yoshida T, Asato Y, Kukita I, Ooshiro M, Takara I, Iha H, et al. A 7-year-old boy with mycoplasmal infection requiring extracorporeal membrane oxygenation. Eur J Pediatr 2003;162:44-6. https://doi.org/10.1007/s00431-002-1057-y
  4. Van Bever HP, Van Doorn JW, Demey HE. Adult respiratory distress syndrome associated with Mycoplasma pneumoniae infection. Eur J Pediatr 1992;151:227-8. https://doi.org/10.1007/BF01954392
  5. Kwon JE, Ahn KY, Choi BS. Two patients with Mycoplasma pneumoniae pneumonia progressing to acute respiratory distress syndrome. Allergy Asthma Respir Dis 2017;5:169-74. https://doi.org/10.4168/aard.2017.5.3.169
  6. Park SJ, Pai KS, Kim AR, Lee JH, Shin JI, Lee SY. Fulminant and fatal multiple organ failure in a 12-yearold boy with Mycoplasma pneumoniae infection. Allergy Asthma Immunol Res 2012;4:55-7. https://doi.org/10.4168/aair.2012.4.1.55
  7. Koletsky RJ, Weinstein AJ. Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature. Am Rev Respir Dis 1980;122:491-6.
  8. Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West J Med 1995;162:133-42.
  9. Miyashita N, Obase Y, Ouchi K, Kawasaki K, Kawai Y, Kobashi Y, et al. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol 2007;56:1625-9. https://doi.org/10.1099/jmm.0.47119-0
  10. Noriega ER, Simberkoff MS, Gilroy FJ, Rahal JJ Jr. Life-threatening Mycoplasma pneumoniae pneumonia. JAMA 1974;229:1471-2. https://doi.org/10.1001/jama.1974.03230490059028
  11. Izumikawa K, Izumikawa K, Takazono T, Kosai K, Morinaga Y, Nakamura S, et al. Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature. J Infect Chemother 2014;20:181-5. https://doi.org/10.1016/j.jiac.2013.09.009
  12. Chung EH. Serological diagnosis of Mycoplasma pneumoniae infections. Korean J Pediatr Infect Dis 2006;13:21-30. https://doi.org/10.14776/kjpid.2006.13.1.21
  13. Radisic M, Torn A, Gutierrez P, Defranchi HA, Pardo P. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin Infect Dis 2000;31:1507-11. https://doi.org/10.1086/317498
  14. Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2006;41:263-8. https://doi.org/10.1002/ppul.20374
  15. Tagliabue C, Salvatore CM, Techasaensiri C, Mejias A, Torres JP, Katz K, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. J Infect Dis 2008;198:1180-8. https://doi.org/10.1086/591915
  16. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280:159-65. https://doi.org/10.1001/jama.280.2.159
  17. Priestley MA, Helfaer MA. Approaches in the management of acute respiratory failure in children. Curr Opin Pediatr 2004;16:293-8. https://doi.org/10.1097/01.mop.0000126602.23949.48
  18. Meuers KV, Lally KP, Peek G, Zwischenberger JB. ECMO: extracorporeal cardiopulmonary support in critical care. 3rd ed. Ann Arbor, Michigan: Extracorporeal Life Support Organization, 2005.
  19. Green TP, Timmons OD, Fackler JC, Moler FW, Thompson AE, Sweeney MF. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Crit Care Med 1996;24:323-9. https://doi.org/10.1097/00003246-199602000-00023
  20. Park JM. Continuous renal replacement therapy in children. J Korean Soc Pediatr Nephrol 2009;13:118-29. https://doi.org/10.3339/jkspn.2009.13.2.118
  21. Paden ML, Warshaw BL, Heard ML, Fortenberry JD. Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation. Pediatr Crit Care Med 2011;12:153-8. https://doi.org/10.1097/PCC.0b013e3181e2a596
  22. Mansel JK, Rosenow EC 3rd, Smith TF, Martin JW Jr. Mycoplasma pneumoniae pneumonia. Chest 1989;95:639-46. https://doi.org/10.1378/chest.95.3.639
  23. Kim CK, Chung CY, Kim JS, Kim WS, Park Y, Koh YY. Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia. Pediatrics 2000;105:372-8. https://doi.org/10.1542/peds.105.2.372